10.77
price down icon0.28%   -0.03
after-market Handel nachbörslich: 10.77
loading
Schlusskurs vom Vortag:
$10.80
Offen:
$10.75
24-Stunden-Volumen:
1.73M
Relative Volume:
2.72
Marktkapitalisierung:
$736.50M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-209.96M
KGV:
-3.6263
EPS:
-2.97
Netto-Cashflow:
$-176.27M
1W Leistung:
-13.84%
1M Leistung:
-6.59%
6M Leistung:
+67.24%
1J Leistung:
+3.56%
1-Tages-Spanne:
Value
$10.63
$10.98
1-Wochen-Bereich:
Value
$10.59
$12.73
52-Wochen-Spanne:
Value
$4.92
$12.97

Replimune Group Inc Stock (REPL) Company Profile

Name
Firmenname
Replimune Group Inc
Name
Telefon
(781) 222-9600
Name
Adresse
500 UNICORN PARK, WOBURN, MA
Name
Mitarbeiter
331
Name
Twitter
@Replimune
Name
Nächster Verdiensttermin
2024-11-05
Name
Neueste SEC-Einreichungen
Name
REPL's Discussions on Twitter

Vergleichen Sie REPL mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
REPL 10.77 736.50M 0 -209.96M -176.27M -2.97
VRTX 467.01 119.87B 10.63B -479.80M -1.35B 13.33
REGN 762.00 83.27B 13.85B 4.65B 3.32B 35.06
ARGX 567.90 33.96B 1.86B -40.29M -1.28B -4.16
ALNY 232.27 30.18B 2.09B -332.26M 16.06M -4.14
BNTX 101.87 24.42B 3.30B -501.07M 1.03B 11.54

Replimune Group Inc Stock (REPL) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2023-04-17 Fortgesetzt Piper Sandler Overweight
2021-11-19 Eingeleitet Piper Sandler Overweight
2021-10-15 Fortgesetzt BTIG Research Buy
2020-11-17 Eingeleitet BTIG Research Buy
2020-11-02 Eingeleitet Jefferies Buy
2020-10-15 Hochstufung H.C. Wainwright Neutral → Buy
2020-07-01 Herabstufung H.C. Wainwright Buy → Neutral
2020-05-05 Eingeleitet Barclays Overweight
2019-09-04 Eingeleitet ROTH Capital Buy
2019-07-23 Eingeleitet Chardan Capital Markets Buy
2019-07-12 Hochstufung JP Morgan Neutral → Overweight
2019-07-08 Eingeleitet H.C. Wainwright Buy
2019-04-25 Eingeleitet Wedbush Outperform
2019-01-23 Herabstufung JP Morgan Overweight → Neutral
2018-08-14 Eingeleitet JP Morgan Overweight
2018-08-14 Eingeleitet Leerink Partners Outperform
Alle ansehen

Replimune Group Inc Aktie (REPL) Neueste Nachrichten

pulisher
Nov 17, 2024

Replimune Group Q3 EPS Forecast Decreased by Leerink Partnrs - Defense World

Nov 17, 2024
pulisher
Nov 15, 2024

Q3 Earnings Estimate for Replimune Group Issued By Wedbush - MarketBeat

Nov 15, 2024
pulisher
Nov 15, 2024

HC Wainwright Predicts Stronger Earnings for Replimune Group - MarketBeat

Nov 15, 2024
pulisher
Nov 15, 2024

Leerink Partnrs Weighs in on Replimune Group Q3 Earnings - MarketBeat

Nov 15, 2024
pulisher
Nov 15, 2024

Significant Stake Increase by Baker Bros. Advisors in Replimune Group Inc - GuruFocus.com

Nov 15, 2024
pulisher
Nov 15, 2024

Brokerages Set Replimune Group, Inc. (NASDAQ:REPL) Target Price at $16.80 - Defense World

Nov 15, 2024
pulisher
Nov 14, 2024

When (REPL) Moves Investors should Listen - Stock Traders Daily

Nov 14, 2024
pulisher
Nov 13, 2024

Replimune Group’s Q3 2024 Financial Highlights - TipRanks

Nov 13, 2024
pulisher
Nov 12, 2024

Replimune Group (NASDAQ:REPL) Receives Buy Rating from HC Wainwright - MarketBeat

Nov 12, 2024
pulisher
Nov 12, 2024

Replimune Reports $432.1M Cash Position, Advances Melanoma Treatment BLA Plans | REPL Stock News - StockTitan

Nov 12, 2024
pulisher
Nov 12, 2024

Replimune stock soars to 52-week high, touches $12.86 By Investing.com - Investing.com Australia

Nov 12, 2024
pulisher
Nov 12, 2024

Replimune Group, Inc. (NASDAQ:REPL) Given Average Rating of "Buy" by Analysts - MarketBeat

Nov 12, 2024
pulisher
Nov 12, 2024

Replimune Group Inc. (REPL) Quarterly 10-Q Report - Quartzy

Nov 12, 2024
pulisher
Nov 11, 2024

Replimune stock soars to 52-week high, touches $12.86 - Investing.com India

Nov 11, 2024
pulisher
Nov 11, 2024

Replimune Group (NASDAQ:REPL) Hits New 52-Week HighStill a Buy? - MarketBeat

Nov 11, 2024
pulisher
Nov 11, 2024

Creative Planning Buys 4,699 Shares of Replimune Group, Inc. (NASDAQ:REPL) - Defense World

Nov 11, 2024
pulisher
Nov 09, 2024

Replimune's RP1 Shows 33.6% Response Rate in Melanoma Trial, Marks Breakthrough | REPL Stock News - StockTitan

Nov 09, 2024
pulisher
Nov 08, 2024

Replimune Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times

Nov 08, 2024
pulisher
Nov 08, 2024

Replimune Group Awards Stock Options, RSUs to New Employees in Retention Move | REPL Stock News - StockTitan

Nov 08, 2024
pulisher
Nov 06, 2024

TSX Consumer Staples Capped Index (TTCS) QuotePress Release - The Globe and Mail

Nov 06, 2024
pulisher
Nov 06, 2024

KBW Bank Index (BKX) QuotePress Release - The Globe and Mail

Nov 06, 2024
pulisher
Nov 05, 2024

Itron Inc (ITRI-Q) QuotePress Release - The Globe and Mail

Nov 05, 2024
pulisher
Nov 05, 2024

Vanguard Group's Strategic Acquisition in Replimune Group Inc - GuruFocus.com

Nov 05, 2024
pulisher
Nov 05, 2024

Teledyne Technologies Inc (TDY-N) QuotePress Release - The Globe and Mail

Nov 05, 2024
pulisher
Oct 30, 2024

Replimune to Present at the 39th Annual Meeting of the Society for Immunotherapy of Cancer (SITC) - The Manila Times

Oct 30, 2024
pulisher
Oct 28, 2024

Masco Corp (MAS-N) QuotePress Release - The Globe and Mail

Oct 28, 2024
pulisher
Oct 25, 2024

Skechers U.S.A. (SKX-N) QuotePress Release - The Globe and Mail

Oct 25, 2024
pulisher
Oct 24, 2024

S&P GSCI Index (GNX) QuotePress Release - The Globe and Mail

Oct 24, 2024
pulisher
Oct 23, 2024

Non-melanoma Skin Cancer is Predicted to Exhibit Remarkable Growth During the Study Period (2020–2034) | DelveInsight - GlobeNewswire Inc.

Oct 23, 2024
pulisher
Oct 22, 2024

SG Americas Securities LLC Invests $251,000 in Replimune Group, Inc. (NASDAQ:REPL) - Defense World

Oct 22, 2024
pulisher
Oct 18, 2024

Replimune Group, Inc. (NASDAQ:REPL) Given Average Recommendation of "Buy" by Analysts - MarketBeat

Oct 18, 2024
pulisher
Oct 16, 2024

It would be worthwhile to take a closer look at Replimune Group Inc (REPL) - US Post News

Oct 16, 2024
pulisher
Oct 15, 2024

Daily Progress: Replimune Group Inc (REPL) Drop -7.06, Closing at 10.67 - The Dwinnex

Oct 15, 2024
pulisher
Oct 15, 2024

Replimune Group Inc [REPL] Insider Selling: Time to sell? - Knox Daily

Oct 15, 2024
pulisher
Oct 15, 2024

Replimune Group Inc Inc. (REPL) Price Performance: A Comparative Analysis with Competitors - The InvestChronicle

Oct 15, 2024
pulisher
Oct 14, 2024

Replimune Group (NASDAQ:REPL) Stock Price Down 5.2%Here's What Happened - MarketBeat

Oct 14, 2024
pulisher
Oct 13, 2024

Learn to Evaluate (REPL) using the Charts - Stock Traders Daily

Oct 13, 2024
pulisher
Oct 13, 2024

Cubist Systematic Strategies LLC Buys 53,313 Shares of Replimune Group, Inc. (NASDAQ:REPL) - MarketBeat

Oct 13, 2024
pulisher
Oct 09, 2024

Gaining Ground: Replimune Group Inc (REPL) Closes Higher at 11.74, Up 3.62 - The Dwinnex

Oct 09, 2024
pulisher
Oct 09, 2024

Investing in Replimune Group Inc (REPL) Is Getting More Attractive - Knox Daily

Oct 09, 2024
pulisher
Oct 09, 2024

Replimune Group, Inc. (NASDAQ:REPL) Shares Sold by Dimensional Fund Advisors LP - MarketBeat

Oct 09, 2024
pulisher
Oct 07, 2024

Morgan Stanley's Strategic Reduction in Replimune Group Inc Holdings - GuruFocus.com

Oct 07, 2024
pulisher
Oct 04, 2024

Cubist Systematic Strategies LLC Increases Position in Replimune Group, Inc. (NASDAQ:REPL) - Defense World

Oct 04, 2024
pulisher
Oct 04, 2024

Replimune Group, Inc. (NASDAQ:REPL) Shares Purchased by Millennium Management LLC - MarketBeat

Oct 04, 2024
pulisher
Oct 03, 2024

Chief Financial Officer Hill Emily Luisa sale 8,938 shares of Replimune Group Inc [REPL] - Knox Daily

Oct 03, 2024
pulisher
Oct 02, 2024

Insiders At Replimune Group Sold US$863k In Stock, Alluding To Potential Weakness - Simply Wall St

Oct 02, 2024
pulisher
Oct 02, 2024

Replimune Group (NASDAQ:REPL) Sees Strong Trading Volume - MarketBeat

Oct 02, 2024
pulisher
Oct 02, 2024

REPL’s Stock Market Adventure: 41.16% YTD Growth Amidst Volatility - The InvestChronicle

Oct 02, 2024
pulisher
Oct 01, 2024

Replimune Group (NASDAQ:REPL) Trading Up 6.1% - Defense World

Oct 01, 2024
pulisher
Oct 01, 2024

Is it possible to buy Replimune Group Inc(REPL) shares at a good price now? - US Post News

Oct 01, 2024
pulisher
Oct 01, 2024

Replimune to Present at Two Upcoming Investor Conferences - The Manila Times

Oct 01, 2024

Finanzdaten der Replimune Group Inc-Aktie (REPL)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$18.98
price up icon 3.66%
$76.97
price up icon 1.45%
$39.51
price up icon 7.22%
$359.21
price down icon 1.11%
$187.69
price down icon 0.81%
$101.87
price up icon 2.16%
Kapitalisierung:     |  Volumen (24h):